Increased body mass index, concurrent chemotherapy, epidermal growth factor receptor (EGFR) mutations, increased age, preexisting ILD, tumor infiltration, and concurrent obstruction of central airways are risk factors for early (less than 3 months) occurrence of pneumonitis [42,43]. The gene discussed is EGFR; the disease is interstitial lung disease.